What is hyperuricemia?

Hyperuricemia means there is too much uric acid in your blood. This buildup can lead to gout, a painful form of arthritis that affects the joints.

Can gout and hyperuricemia be treated?

Yes, gout is typically managed with medications that lower uric acid levels. This study will compare an investigational medication to a standard therapy to determine its safety and effectiveness in reducing uric acid levels.

What causes high uric acid levels?

High uric acid can result from genetics, diet (especially foods high in purines), dehydration, obesity, certain medications, or kidney problems.

Will my information remain private?

Yes. All your personal and health-related information will be kept confidential under HIPAA (Health Insurance Portability and Accountability Act) guidelines.

Do I have to pay to be a part of the Hyperuricemia and Gout Clinical Trials near me?

Participation in the Hyperuricemia and Gout Clinical Trials in Michigan is free of cost to you and your health insurance. If you qualify and decide to participate, you will be compensated for your time and travel. Details of the stipend will be given to you once you complete the screening process and move on to the informed consent process.

Systemic Lupus Erythematosus Clinical Trials

Home | Rheumatology | Systemic Lupus Erythematosus Clinical Trials

Living with the Challenges of Lupus?

Discover a New Path to Wellness Through Systemic Lupus Erythematosus Clinical Trials

Systemic lupus erythematosus (SLE) is a chronic autoimmune condition where the immune system mistakenly attacks healthy tissues, causing inflammation that can affect the skin, joints, kidneys, lungs, and other organs. Flare-ups are unpredictable, and symptoms often interfere with daily life.

Revive Research Institute is conducting systemic lupus erythematosus clinical trials to study investigational treatments for systemic lupus erythematosus that may help manage or reduce disease activity. This study focuses on evaluating the safety and effectiveness of potential therapies that could offer potential relief for individuals living with lupus.

To be eligible for SLE clinical trials in Michigan, participants must:

Be 18 to 70 of age or older
Have been diagnosed with lupus (SLE) for at least 6 months

*Additional eligibility criteria may apply

*Participation in systemic lupus erythematosus clinical trials may provide access to expert medical care, regular health monitoring, and investigational therapies at no cost. Health insurance is not required to take part in these studies.

X/Twitter

This field is for validation purposes and should be left unchanged.

Who is this information for?*(Required)

A Family Member

A Friend

My Patient

Please provide YOUR contact information only.

Name(Required)

Phone Number(Required)

Best Time to Call(Required)

Morning

Middle of the day

Evening

Select State(Required)

How did you hear about us?(Required)

Comments

User Agreement(Required)

By Signing up, I agree to be contacted via calls and SMS.

For more info, please visit Privacy Policy.

About the Systemic Lupus Erythematosus Clinical Trial

Systemic lupus erythematosus (SLE) can cause fatigue, joint pain, skin rashes, and organ complications. Despite available treatments, many individuals continue to experience disease flare-ups or medication side effects.

Revive Research Institute is conducting a clinical study for systemic lupus erythematosus to evaluate an investigational treatment for systemic lupus erythematosus. This study aims to discover whether new therapies can help control symptoms and prevent organ damage associated with lupus.

Participants who meet eligibility after the screening process and qualify for enrollment will receive study-related care, lab assessments, and the investigational medication at no cost.

*All study procedures, doctor visits, and study-related medications are provided free of charge. Insurance is not required, and participants may be compensated for time and travel.

*To take the next step, complete the form above, and a member of our clinical research team will contact you for a brief pre-screening. You’ll discuss your health history and learn if you qualify for the study.

Get Started: What to Expect?

If you qualify for a systemic lupus erythematosus clinical trial in Michigan, you may have access to promising potential treatment options designed to manage lupus symptoms more effectively.

After submitting your information, our research team will contact you for a short pre-screening call. If you meet initial requirements, you will be invited to our research site for a screening visit, where we will review your medical history, perform physical exams, and run lab tests.

Those who qualify will review and sign an informed consent form (ICF), explaining study procedures, potential risks, and benefits. Once enrolled, you will receive investigational treatment and ongoing care from our dedicated research staff.

Our team ensures every participant understands their role and feels supported throughout the study. By participating, you help advance systemic lupus erythematosus treatment options that could benefit future patients.

Age:

18 to 70 years of age

Condition:

Systemic Lupus Erythematosus (SLE)

Location

Michigan

Understanding Systemic Lupus Erythematosus

Common Symptoms Include:

Persistent fatigue and joint pain
Butterfly-shaped rash across the cheeks and nose
Muscle pain and swelling
Fever, photosensitivity, or mouth ulcers
Kidney or heart complications

Common Risk Factors:

Female
Family history of autoimmune diseases
Hormonal changes
Certain medications or infections

Currently, there is no cure for lupus, making systemic lupus erythematosus clinical trials vital for discovering safer and more effective therapies. Participating in systemic lupus erythematosus clinical trials Michigan helps accelerate progress toward better treatment and quality of life.

Frequently Asked Questions (FAQs)

1. What is systemic lupus erythematosus?

It’s a chronic autoimmune disease that causes your immune system to attack healthy tissues, leading to inflammation and damage in different parts of the body.

2. Why is lupus considered serious?

SLE can cause irreversible organ damage, extreme fatigue, joint pain, and complications in the kidneys, heart, or lungs if not properly managed.

3. How is lupus treated now?

Current treatments include corticosteroids, immunosuppressants, and antimalarial drugs. However, they may not work for everyone, which is why systemic lupus erythematosus clinical trials are exploring better options.

4. Why should I participate in a clinical trial?

By joining a clinical study for systemic lupus erythematosus, you can access investigational therapies at no cost, receive specialized care, and contribute to developing new systemic lupus erythematosus treatment options that could improve outcomes for future patients.